GlassScriptPhysician profile
Allen L Spires
NPI 1972690741
$10,627.55
in general payments reported to CMS, 2019-2025
43 companies · $1,217 in 2025
The $1,217 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,025 · 2020: $631 · 2021: $1,774 · 2022: $1,761 · 2023: $1,503 · 2024: $1,717 · 2025: $1,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,436.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,140.46 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Amgen INC. | $1,280.16 | 2019-2025 | Repatha, Otezla, Otezla |
| Janssen Pharmaceuticals, INC | $701.64 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $691.01 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $557.60 | 2019-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $523.69 | 2022-2025 | |
| Astellas Pharma US INC | $432.72 | 2021-2025 | Veozah, Myrbetriq |
| Axsome Therapeutics, INC. | $425.03 | 2024-2025 | Auvelity |
| Novartis Pharmaceuticals Corporation | $409.90 | 2019-2022 | |
| Pfizer INC. | $386.98 | 2019-2024 | |
| Nestle Healthcare Nutrition INC. | $365.24 | 2021-2023 | |
| Avanir Pharmaceuticals, INC. | $252.61 | 2020-2022 | |
| Glaxosmithkline, LLC. | $236.89 | 2019-2025 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $236.71 | 2021-2023 | Verquvo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $182.32 | 2022-2025 | Caplyta |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Spires listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.